MRI showed more than 90% sensitivity in detecting nasopharyngeal carcinoma (NPC), surpassing endoscopy’s detection rate of 65.6% over a 5-year period. MRI particularly excelled in identifying ...
A gene based model using nasopharyngeal carcinoma biomarkers AURKA and BUB1 accurately predicts survival and demonstrates ...
After radiation therapy, certain cancer patients face a lingering question: Is a troubling lesion a return of the cancer, or ...
Shifting burden of nasopharyngeal carcinoma: global patterns and forecasts to 2050 from the GBD 2021
Background: Nasopharyngeal carcinoma (NPC) exhibits pronounced geographical variation, with a high burden in specific regions. We assessed global, regional, and national trends in NPC burden from 1990 ...
Background: The triglyceride-glucose (TyG) index, a simple marker of insulin resistance, has shown prognostic value in various malignancies. However, its predictive utility for survival in ...
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...
The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal carcinoma treatment, yet only a minority of patients achieve durable responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback